Association of tumor-infiltrating lymphocytes with clinical outcomes in patients with triple-negative breast cancer receiving neoadjuvant chemotherapy: a systematic …
FCA de Moraes, MEC Souza, VKT Sano… - Clinical and …, 2024 - Springer
Objective Triple-negative breast cancer (TNBC) presents a clinical challenge as an
aggressive tumor, correlated with unfavorable prognosis. Tumor-infiltrating lymphocytes …
aggressive tumor, correlated with unfavorable prognosis. Tumor-infiltrating lymphocytes …
Omitting axillary lymph node dissection is associated with an increased risk of regional recurrence in early stage breast cancer: a systematic review and meta-analysis …
JHCO Cardoso, ICA de Lara, LER Sobreira… - Clinical Breast …, 2024 - Elsevier
Background Breast cancer (BC) is a global problem, however, despite ALND is considered
the standard treatment for early stage BC with node-positive, there is no sufficient data to …
the standard treatment for early stage BC with node-positive, there is no sufficient data to …
A systematic review and meta-analysis of users versus non-users: unveiling the influence of proton pump inhibitors on capecitabine efficacy in colorectal cancer
FCA de Moraes, EA de Laia, VKT Sano… - Expert Review of …, 2024 - Taylor & Francis
Introduction Colorectal cancer is the second leading cause of cancer-related deaths
worldwide. The impact of proton pump inhibitors (PPIs) on patients taking capecitabine, an …
worldwide. The impact of proton pump inhibitors (PPIs) on patients taking capecitabine, an …
HLA-I and breast cancer prognosis: A systematic review and meta-analysis
FCA de Moraes, JHCO Cardoso, FA Kelly, M Kreuz… - Human Immunology, 2024 - Elsevier
Background Breast cancer (BC) is a significant global health issue, accounting for 1 in 8
cancer diagnoses worldwide. HLA class I molecules are typically expressed on the cell …
cancer diagnoses worldwide. HLA class I molecules are typically expressed on the cell …
Application of Meta-analysis for Determining Cancer Biomarkers
Hİ Pazarbaşı, A Pavlopoulou - Arşiv Kaynak Tarama Dergisi, 2024 - dergipark.org.tr
The health care professionals are facing the challenge to combine and translate the findings
from a plethora of, often conflicting, clinical trials or clinical studies in order to reach an …
from a plethora of, often conflicting, clinical trials or clinical studies in order to reach an …
The Effect of Proton Pump Inhibitors on Metastatic Breast Cancer in Patients Treated with CDK4/6i
M Khalifa, A Mohammed, Y Mohamed… - Middle East Journal …, 2024 - mejc.sums.ac.ir
Background: This study aimed to assess the effect of proton pump inhibitors (PPIs) on
hormone receptor-positive (HR+) and her-2-negative (her2-) metastatic breast cancer (MBC) …
hormone receptor-positive (HR+) and her-2-negative (her2-) metastatic breast cancer (MBC) …